Press Releases

Date Title and Summary  
Toggle Summary Geron Reports Imetelstat Presentation at American Association for Cancer Research Annual Meeting
MENLO PARK, Calif. , April 05, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced a poster presentation by Janssen Research & Development, LLC describing non-clinical data on the telomerase inhibitor imetelstat at the 2017 American Association for Cancer Research (AACR) Annual
Toggle Summary Geron Announces Presentation at American Association for Cancer Research Annual Meeting
MENLO PARK, Calif. , March 02, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced an abstract submitted by Janssen Research & Development, LLC describing non-clinical data on imetelstat has been accepted for presentation as a poster at the 2017 American Association for Cancer
Toggle Summary Geron Corporation Reports Fourth Quarter and Annual 2016 Financial Results
Conference Call Scheduled for 4:30 p.m. ET Today, March 1 MENLO PARK, Calif. , March 01, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the fourth quarter and year ended December 31, 2016 and recent events.
Toggle Summary Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2016 Financial Results
MENLO PARK, Calif. , Feb. 22, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the fourth quarter and year ended December 31, 2016 , on Wednesday, March 1, 2017 , after the market close. Geron’s management will also host a conference call for analysts
Toggle Summary Geron Reports Imetelstat Presentations at American Society of Hematology Annual Meeting
MENLO PARK, Calif. , Dec. 06, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced four presentations of exploratory preclinical and clinical data related to the imetelstat program at the 58th American Society of Hematology (ASH) Annual Meeting and Exposition held in San Diego,
Toggle Summary Geron Announces November Investor Conference Presentation Webcasts
MENLO PARK, Calif. , Nov. 07, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett , M.D., President and Chief Executive Officer, is scheduled to present at the following investor conferences: Stifel 2016 Healthcare Conference in New York at 9:30 a.m.
Toggle Summary Geron Corporation Reports Third Quarter 2016 Financial Results and Recent Events
Conference Call Scheduled for 4:30 p.m. EDT Today, November 3 MENLO PARK, Calif. , Nov. 03, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the three and nine months ended September 30, 2016 and recent events.
Toggle Summary Geron Announces Presentations at American Society of Hematology Annual Meeting
MENLO PARK, Calif. , Nov. 03, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that four abstracts related to the imetelstat program have been accepted for presentation at the 58th American Society of Hematology (ASH) Annual Meeting and Exposition to be held in San Diego,
Toggle Summary Geron Announces Conference Call to Discuss Third Quarter 2016 Financial Results
MENLO PARK, Calif. , Oct. 26, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the third quarter ended September 30, 2016 , on Thursday, November 3, 2016 , after the market close. Geron’s management will also host a conference call for analysts and
Toggle Summary Geron Provides Update on Imetelstat Trials Being Conducted by Janssen
Conference Call Scheduled for 8:00 a.m. EDT Today, September 12 MENLO PARK, Calif. , Sept. 12, 2016 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today provided updates on the clinical trials being conducted by Janssen Research & Development, LLC , of the telomerase inhibitor imetelstat.